Literature DB >> 29728817

LGE-CMR-derived texture features reflect poor prognosis in hypertrophic cardiomyopathy patients with systolic dysfunction: preliminary results.

Sainan Cheng1, Mengjie Fang2,3, Chen Cui1, Xiuyu Chen1, Gang Yin1, Sanjay K Prasad4, Di Dong5,6, Jie Tian2,3, Shihua Zhao7.   

Abstract

OBJECTIVES: To evaluate the prognostic value of texture features based on late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) images in hypertrophic cardiomyopathy (HCM) patients with systolic dysfunction.
METHODS: 67 HCM patients with systolic dysfunction (41 male and 26 female, mean age ± standard deviation, 46.20 years ± 13.38) were enrolled. All patients underwent 1.5 T CMR cine and LGE imaging. Texture features were extracted from LGE images. Cox proportional hazard analysis and Kaplan-Meier analysis were used to determine the association of texture features and traditional parameters with event free survival.
RESULTS: Family history (hazard ratio [HR]=2.558, 95 % confidence interval [CI]=1.060-6.180), NYHA III-IV (HR=5.627, CI=1.652-19.173), left ventricular ejection fraction (HR=0.945, CI=0.902-0.991), left ventricular end-diastolic volume index (HR=1.006, CI=1.000-1.012), LGE extent (HR=1.911, CI=1.348-2.709) and three texture parameters [X0_H_skewness (HR=0.783, CI=0.691-0.889), X0_GLCM_cluster_tendency (HR=0.735, CI=0.616-0.877) and X0_GLRLM_energy (HR=1.344, CI=1.173-1.540)] were significantly associated with event free survival in univariate analysis (p<0.05). The HR of LGE extent (HR=1.548 [CI=1.046-2.293], 1.650 [CI=1.122-2.428] and 1.586 [CI=1.044-2.409] per 10 % increase, p<0.05) remained significant when adjusted by one of the three texture features.
CONCLUSION: Increased LGE heterogeneity (higher X0_GLRLM_energy, lower X0_H_skewness and lower X0_GLCM_cluster_tendency) was associated with adverse events in HCM patients with systolic dysfunction. KEY POINTS: • Textural analysis from CMR can be applied in HCM. • Texture features derived from LGE images can capture fibrosis heterogeneity. • CMR texture analysis provides prognostic information in HCM patients.

Entities:  

Keywords:  Cardiac magnetic resonance; Event-free survival; Hypertrophic cardiomyopathy; Late gadolinium enhancement; Texture features

Mesh:

Substances:

Year:  2018        PMID: 29728817     DOI: 10.1007/s00330-018-5391-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  30 in total

1.  Pretreatment Prognostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Vascular, Texture, Shape, and Size Parameters Compared With Traditional Survival Indicators Obtained From Locally Advanced Breast Cancer Patients.

Authors:  Martin D Pickles; Martin Lowry; Peter Gibbs
Journal:  Invest Radiol       Date:  2016-03       Impact factor: 6.016

2.  Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Evan Appelbaum; Caitlin J Harrigan; Jacki Buros; C Michael Gibson; Connie Hanna; John R Lesser; James E Udelson; Warren J Manning; Barry J Maron
Journal:  Circ Heart Fail       Date:  2008-06-23       Impact factor: 8.790

3.  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).

Authors:  Karen A Hicks; James E Tcheng; Biykem Bozkurt; Bernard R Chaitman; Donald E Cutlip; Andrew Farb; Gregg C Fonarow; Jeffrey P Jacobs; Michael R Jaff; Judith H Lichtman; Marian C Limacher; Kenneth W Mahaffey; Roxana Mehran; Steven E Nissen; Eric E Smith; Shari L Targum
Journal:  J Am Coll Cardiol       Date:  2014-12-29       Impact factor: 24.094

4.  LGE Means Better Selection of HCM Patients for Primary Prevention Implantable Defibrillators.

Authors:  Barry J Maron; Martin S Maron
Journal:  JACC Cardiovasc Imaging       Date:  2016-07-20

5.  Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models.

Authors:  Philipp Kickingereder; Sina Burth; Antje Wick; Michael Götz; Oliver Eidel; Heinz-Peter Schlemmer; Klaus H Maier-Hein; Wolfgang Wick; Martin Bendszus; Alexander Radbruch; David Bonekamp
Journal:  Radiology       Date:  2016-06-20       Impact factor: 11.105

6.  Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

7.  Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival.

Authors:  Francesca Ng; Balaji Ganeshan; Robert Kozarski; Kenneth A Miles; Vicky Goh
Journal:  Radiology       Date:  2012-11-14       Impact factor: 11.105

8.  Tumor Heterogeneity in Lung Cancer: Assessment with Dynamic Contrast-enhanced MR Imaging.

Authors:  Soon Ho Yoon; Chang Min Park; Sang Joon Park; Jeong-Hwa Yoon; Seokyung Hahn; Jin Mo Goo
Journal:  Radiology       Date:  2016-03-31       Impact factor: 11.105

9.  Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy.

Authors:  Tevfik F Ismail; Andrew Jabbour; Ankur Gulati; Amy Mallorie; Sadaf Raza; Thomas E Cowling; Bibek Das; Jahanzaib Khwaja; Francisco D Alpendurada; Ricardo Wage; Michael Roughton; William J McKenna; James C Moon; Amanda Varnava; Carl Shakespeare; Martin R Cowie; Stuart A Cook; Perry Elliott; Rory O'Hanlon; Dudley J Pennell; Sanjay K Prasad
Journal:  Heart       Date:  2014-06-24       Impact factor: 5.994

10.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

View more
  17 in total

1.  Quality of science and reporting for radiomics in cardiac magnetic resonance imaging studies: a systematic review.

Authors:  Suyon Chang; Kyunghwa Han; Young Joo Suh; Byoung Wook Choi
Journal:  Eur Radiol       Date:  2022-03-01       Impact factor: 5.315

Review 2.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 3.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

4.  Image resampling and discretization effect on the estimate of myocardial radiomic features from T1 and T2 mapping in hypertrophic cardiomyopathy.

Authors:  Daniela Marfisi; Carlo Tessa; Chiara Marzi; Jacopo Del Meglio; Stefania Linsalata; Rita Borgheresi; Alessio Lilli; Riccardo Lazzarini; Luca Salvatori; Claudio Vignali; Andrea Barucci; Mario Mascalchi; Giancarlo Casolo; Stefano Diciotti; Antonio Claudio Traino; Marco Giannelli
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

Review 5.  Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment.

Authors:  Efstathios D Pagourelias; Georgios M Alexandridis; Vassilios P Vassilikos
Journal:  Heart Fail Rev       Date:  2021-05-15       Impact factor: 4.214

Review 6.  Cardiac magnetic resonance imaging in the evaluation of patients with hypertrophic cardiomyopathy.

Authors:  Juan Carlos Brenes; Adelina Doltra; Susanna Prat
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

Review 7.  Machine learning in cardiovascular magnetic resonance: basic concepts and applications.

Authors:  Tim Leiner; Daniel Rueckert; Avan Suinesiaputra; Bettina Baeßler; Reza Nezafat; Ivana Išgum; Alistair A Young
Journal:  J Cardiovasc Magn Reson       Date:  2019-10-07       Impact factor: 5.364

8.  Prognostic Value of Late Enhanced Cardiac Magnetic Resonance Imaging Derived Texture Features in Dilated Cardiomyopathy Patients With Severely Reduced Ejection Fractions.

Authors:  Shenglei Shu; Cheng Wang; Ziming Hong; Xiaoyue Zhou; Tianjng Zhang; Qinmu Peng; Jing Wang; Chuansheng Zheng
Journal:  Front Cardiovasc Med       Date:  2021-12-17

Review 9.  Artificial intelligence: improving the efficiency of cardiovascular imaging.

Authors:  Andrew Lin; Márton Kolossváry; Ivana Išgum; Pál Maurovich-Horvat; Piotr J Slomka; Damini Dey
Journal:  Expert Rev Med Devices       Date:  2020-06-16       Impact factor: 3.166

10.  Cardiac magnetic resonance radiomics: basic principles and clinical perspectives.

Authors:  Zahra Raisi-Estabragh; Cristian Izquierdo; Victor M Campello; Carlos Martin-Isla; Akshay Jaggi; Nicholas C Harvey; Karim Lekadir; Steffen E Petersen
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-04-01       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.